Luts & Greenleigh Group, Inc Bristol Myers Squibb CO Transaction History
Luts & Greenleigh Group, Inc
- $96.1 Billion
- Q2 2024
A detailed history of Luts & Greenleigh Group, Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Luts & Greenleigh Group, Inc holds 7,320 shares of BMY stock, worth $359,631. This represents 0.32% of its overall portfolio holdings.
Number of Shares
7,320Holding current value
$359,631% of portfolio
0.32%Shares
1 transactions
Others Institutions Holding BMY
# of Institutions
2,400Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$9.17 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.79 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.49 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.67 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$2.9 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $104B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...